Merck to buy drug developer Pandion Therapeutics for $1.85 bln

Shares of Pandion rose 131.6% to a record high of $59.37 before the bell, while Merck shares were up about 1%. Pandion's lead drug candidate, PT101, met its main goals of safety and tolerability last month in an early-stage trial in patients with autoimmune diseases. Merck was represented by Credit Suisse Securities, Covington & Burling, while Centerview Partners LLC and Skadden, Arps, Slate, Meagher & Flom LLP represented Pandion.

Reuters | Updated: 25-02-2021 18:14 IST | Created: 25-02-2021 18:09 IST
Merck to buy drug developer Pandion Therapeutics for $1.85 bln
Representative image. Image Credit: Wikimedia

Merck & Co Inc said on Thursday it would buy drug developer Pandion Therapeutics Inc for about $1.85 billion in cash, expanding its portfolio of drugs that target autoimmune diseases.

The $60-per-share deal represents about 134% premium to Pandion's closing price on Wednesday. Shares of Pandion rose 131.6% to a record high of $59.37 before the bell, while Merck shares were up about 1%.

Pandion's lead drug candidate, PT101, met its main goals of safety and tolerability last month in an early-stage trial in patients with autoimmune diseases. In November, Merck agreed to buy privately-held VelosBio for $2.75 billion to strengthen its cancer drug portfolio as the drugmaker looks to reduce its reliance on its blockbuster cancer therapy Keytruda.

The deal between Merck and Pandion is expected to close in the first half of 2021, the companies said in a joint statement. Merck was represented by Credit Suisse Securities, Covington & Burling, while Centerview Partners LLC and Skadden, Arps, Slate, Meagher & Flom LLP represented Pandion.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Viral variants and vaccine nationalism pose two-pronged threat to Covid victory

... ...

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

World Water Day sees crises of inequality in countries both rich and poor

... ...

Videos

Latest News

Macron says nations must 'define red lines' with Russia

French President Emmanuel Macron says that while dialogue with Russia is essential, clear red lines carrying possible sanctions must also be drawn with Moscow over Ukraine. Referring to a recent buildup of Russian troops on Ukraines border,...

Rockets strike Iraqi military base hosting U.S. contractors, security officials say

At least five rockets hit the Iraqi military air base at Balad north of Baghdad on Sunday, Iraqi security officials said.The officials said the Katyusha rockets had fallen on the area of the base that houses U.S. contractors, and that no ca...

UK records another 1,882 coronavirus cases, 10 deaths

London UK, April 18 ANIXinhua Another 1,882 people in Britain have tested positive for COVID-19, bringing the total number of coronavirus cases in the country to 4,387,820, according to official figures released Sunday. The country also rep...

Actor complains against realtor over non-payment of loan

Hyderabad, Apr 18 PTI A Telugu actor has filed a police complaint saying a realtor had cheated him and his family of Rs 7.5 crore.In a video message on Sunday, the actor Naresh said the realtor had borrowedthe amount six years ago butdid no...

Give Feedback